[我如何治疗儿科慢性髓性白血病]
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
儿童慢性髓性白血病 (CML) 治疗已通过氨酸激酶抑制剂 (TKIs) 得到改善. 该指南提供了诊断和管理的标准化建议,优先考虑技术知识,并为高级病例保留干细胞移植.
科学领域:
- 血液学 血液学 血液学
- 儿科瘤学 儿科瘤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿童慢性髓性白血病 (CML) 提出了独特的挑战,比成人CML更具侵略性.
- 氨酸激酶抑制剂 (TKIs) 已经彻底改变了CML治疗,显著改善了治疗结果.
研究的目的:
- 建立对儿科CML的标准化诊断和治疗建议.
- 以指导初始治疗选择,疗效评估和不良反应管理.
- 为了优化治疗策略对于具有挑战性的儿科CML病例.
主要方法:
- 根据国际共识和临床经验制定建议.
- 审查当前的治疗方法,包括TKIs和全源造血干细胞移植 (allo-HSCT).
- 案例研究分析以说明常见的治疗挑战.
主要成果:
- 技术知识测试是儿科CML治疗的基石,对加速和爆发阶段提出了具体建议.
- 全基性造血干细胞移植 (allo-HSCT) 仅适用于耐火性或晚期疾病.
- 标准化管理协议旨在提高反应率和管理药物不耐受性.
结论:
- 基于TKI的标准化治疗方案对于优化儿科CML结果至关重要.
- 精心选择患者和及时进行治疗调整对于管理CML至关重要.
- 需要进一步的多中心研究来探索儿科CML的无治疗缓解.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Differentiation of Common Myeloid Progenitor Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Treatment Resistant Cancers
